Skip to main content
. 2011 Oct 11;6:97. doi: 10.1186/1746-1596-6-97

Table 2.

Combination of GC-marker immunoreactivity in the series of FL

Triple-positive
N.cases (%)
Double-positive
N.cases (%)
Single-positive
N.cases (%)
Groups (N.cases) HGAL/BCL6/CD10 HGAL/BCL6 HGAL/CD10 BCL6 HGAL

In situ FL (6) 3 (50%) - 3 (50%) - -

Nodal FL (61) 53 (87.1%) 4 (6.5%) 2 (3.2%) 2 (3.2%) -

FL+LBCL (10) 8 (80%) 1 (10%) - - 1 (10%)

CFL (5) 5 (100%) - - - -

Total (82) 69 (84.2%) 5 (6.1%) 5 (6.1%) 2 (2.4%) 1 (1.2%)